Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 7, 1997, Pages 530-532

  Hazell, S L ^a   Mitchell, H M ^a   Hanna, G ^a   Daskalopoulos, G ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Inner West Endoscopy Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM; STOMACH BIOPSY; STRAIN DIFFERENCE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; BIOPSY; DOUBLE-BLIND METHOD; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OMEPRAZOLE; PROTON PUMPS; PYLORIC ANTRUM; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

EID: 0030742131     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01708237     Document Type: Article

References (15)

1. Chiba N, Rao BV, Rademaker JW, Hunt RH: Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. American Journal of Gastroenterology 1992, 87: 1716-1727.
2. Bell GD, Powell K, Burridge SM, Pallecaros A, Jones PH, Gant PW, Harrison G, Trowell JE: Experience with triple anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance. Alimentary Pharmacology and Therapeutics 1992, 6: 427-435.
3. Iwahi T, Satoh H, Nakao M, Iwasaki T, Yamazaki T, Kubo K, Tamura T, Imada A: Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrobial Agents and Chemotherapy 1991, 35: 490-496.
4. Deboer W, Driessen W, Jansz A, Tytgat G: Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995, 345: 817-820.
5. Jorgensen M, Daskalopoulos G, Warburton V, Mitchell HM, Hazell SL: Multiple strain colonisation and metronidazole resistance in Helicobacter pylori infected patients: identification from sequential and multiple biopsy specimens. Journal of Infectious Diseases 1996, 174:631-635.
6. Hazell SL, Daskalopoulos G, Mitchell HM, Massey D: Lansoprazole and amoxycillin: observations on the treatment of Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 1997, 12: 93-99.
7. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE: DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Research 1992, 20: 5137-5142.
8. Marshall DG, Chua A, Keeling PWN, Sullivan DJ, Coleman DC, Smyth CJ: Molecular analysis of Helicobacter pylori populations in antral biopsies from individual patients using randomly amplified polymorphic DNA finger-printing. FEMS Immunology and Medical Microbiology 1995, 10: 317-324.
9. Salama SM, Jiang Q, Chang N, Sherbaniuk RW, Taylor DE: Characterisation of chromosomal DNA profiles from Helicobacter pylori strains isolated from sequential gastric biopsy specimens. Journal of Clinical Microbiology 1995,33:2496-2497.
10. Taylor NS, Fox JG, Akopyants NS, Berg DE, Thompson N, Shames B, Yan L, Fontham E, Janney F, Hunter FM, Correa P: Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. Journal of Clinical Microbiology 1995, 33: 918-923.
11. Owen RJ, Bell GD, Desai M, Moreno M, Gant PW, Jones PH, Linton D: Biotype and molecular fingerprints of metronidazole resistant strains of Helicobacter pylori from antral gastric mucosa. Journal of Medical Microbiology 1993, 38: 6-12.
12. Hirschl AM, Richter M, Makristathis A, Pruckl PM, Willinger B, Schutze K, Rotter ML: Single and multiple strain colonisation in patients with Helicobacter pylori associated gastritis: detection by macrorestriction DNA analysis. Journal of Infectious Diseases 1994, 170: 473-475.
13. Fraser AG, Bickley J, Owen RJ, Pounder RE: DNA fingerprints of Helicobacter pylori before and after treatment with omeprazole. Journal of Clinical Pathology 1992, 45: 1062-1065.
14. Hazell SL, Andrews RH, Mitchell HM, Daskalopoulos G: Genetic relationship among isolates of Helicobacter pylori: evidence for the existence of a Helicobacter pylori species-complex. FEMS Microbiology Letters 1997, 150: 27-32.
15. Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH: Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995, 36: 12-16.